Tacrolimus [clinicaltrials_resource:27326813125e85301cd643b58287f20b]
Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis [clinicaltrials:NCT00615173]Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS) [clinicaltrials:NCT00615667]a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients [clinicaltrials:NCT01055964]Improving Medication-taking After Liver Transplant [clinicaltrials:NCT01960322]
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00002831Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [clinicaltrials:NCT00003572]A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant [clinicaltrials:NCT00005113]Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006350]clinicaltrials:NCT00023244Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing [clinicaltrials:NCT00028171]Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis [clinicaltrials:NCT00036153]clinicaltrials:NCT00038948clinicaltrials:NCT00049504clinicaltrials:NCT00064701clinicaltrials:NCT00076570clinicaltrials:NCT00078559Study of Therapeutic Monitoring of CellCept (Mycophenolate Mofetil) After Kidney Transplantation [clinicaltrials:NCT00087581]Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00089037]Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00096096]clinicaltrials:NCT00096460Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00105001]clinicaltrials:NCT00105235clinicaltrials:NCT00106392clinicaltrials:NCT00106496clinicaltrials:NCT00106639clinicaltrials:NCT00109993clinicaltrials:NCT00113269A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma [clinicaltrials:NCT00116103]Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis [clinicaltrials:NCT00117377]Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection [clinicaltrials:NCT00117689]clinicaltrials:NCT00117702clinicaltrials:NCT00118742clinicaltrials:NCT00119158clinicaltrials:NCT00120523clinicaltrials:NCT00121186Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients [clinicaltrials:NCT00121316]Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis [clinicaltrials:NCT00121381]Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis [clinicaltrials:NCT00125307]Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca [clinicaltrials:NCT00128245]Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis [clinicaltrials:NCT00130364]Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection [clinicaltrials:NCT00133172]Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [clinicaltrials:NCT00133367]Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer [clinicaltrials:NCT00134017]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Tacrolimus [clinicaltrials_resource:27326813125e85301cd643b58287f20b]
Bio2RDF identifier
27326813125e85301cd643b58287f20b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:27326813125e85301cd643b58287f20b
identifier
clinicaltrials_resource:27326813125e85301cd643b58287f20b
title
Tacrolimus
@en
type
label
Tacrolimus [clinicaltrials_resource:27326813125e85301cd643b58287f20b]
@en